High dietary acid load predicts severity of autoimmune skin disease: a cross-sectional study Authors: Maryam Fallah, Banafsheh Jafari Azad, Anahita Najafi, Zahra Esmaeily, Kamran Balighi, Maryam Daneshpazhooh, Soraiya Ebrahimpour-Koujan Published: 2024 ABSTRACT AbstractNo previous study has examined the association of an acid-base imbalanced diet to autoimmune bullous disease. The present study aimed to investigate the association between dietary acid load (DAL) as either potential renal acid load (PRAL) and net endogenous acid production (NEAP) intake on the odds of high-severity Pemphigus Vulgaris (PV) disease in adult Iranian patients to fill this gap. A cross-sectional study was conducted on 138 patients, aged 18–65 years with confirmed diagnoses of PV in a referral university center for autoimmune bullous diseases. The dietary intakes of all patients during the last year before enrollment in the study were assessed using a 168-item semi-quantitative food frequency questionnaire. Dietary acid load was calculated based on the PRAL and NEAP scores. To assess PV severity, the pemphigus disease area index (PDAI) score was used. Logistic regression was used to evaluate the association between DAL and PDAI. A positive association was observed between PRAL and PDAI score in the crude (adjusted R2 = 0.088, B = 6.88, P < 0.0001) and all other adjusted models, as well as the crude model for NEAP (adjusted R2 = 0.037, B = 4.72, P = 0.013). In terms of adherence to NEAP and PRAL, those in the top tertile of PRAL and NEAP had a higher vulnerability for severe PV in unadjusted (OR = 5.18, 95% (CI) 2.19–12.25) and (OR = 2.48, 95% (CI) 1.08–5.68) respectively. In the present study, we found a significant direct association between DAL and severity of disease in PV patients. Further studies are required to confirm these findings.Keywords: Pemphigus Vulgaris, Dietary acid load, DAL, PRAL, NEAP, PDAISubject terms: Diseases, Medical research Introduction Pemphigus is a rare, chronic, blistering, and potentially fatal autoimmune disease that significantly affects skin and general health1. In general, pemphigus can be divided into two main forms, pemphigus vulgaris (PV) and pemphigus foliaceus (PF). So far, PV has been described as one of the most common and severe subtypes of the disease2. PV is caused by the production of autoantibodies against epithelial intercellular components, particularly cadherin, and desmoglein3,4. This antigen-antibody reaction results in blisters3,4. Blisters typically develop on skin and mucous membranes, starting in the mouth and spreading to other parts of the body5. The disease mainly affects people over the age of 40, with an incidence of 1 per 100,000 per year in Iran, which is higher than in other parts of the world6–8. It has been reported that the smallness of the blister lesions and the mildness of the disease before treatment lead to a better prognosis and disease control9. Therefore, identifying factors involved in the occurrence and development of PV and finding effective strategies to prevent, delay, or ameliorate this condition is critical and required. Genetic and environmental factors are involved in the pathogenesis of PV10. Certain medications, hormonal changes, radiation therapy, diseases, vaccines, nutrients, micronutrients, pregnancy, and emotional stress can cause or worsen pemphigus in those sensitive people11–14. Nutritional factors be central to PV-related environmental factors and play an important role in its manifestation and management12,15–17. It seems that a diet with low alkaline foods (including fruits, vegetables, legumes, potatoes, and red wine) and acidic foods (including meat, fish, cheese, rice, and grains) can produce endogenous acid and increase Dietary acid load (DAL) prevents the body from optimal acid-base balance maintenance18–20. DAL can be calculated by 3 methods, which are potential net renal acid load (PRAL), net acid excretion (NAE, which indicates excess dietary anions), and net endogenous acid excretion (NEAP)19,21,22. Although PRAL can measure dietary protein intake and several micronutrients such as potassium, magnesium, calcium, and phosphorus, as well as the rate of nutrient absorption at the intestinal border, the most relevant method is DAL measurement23. Several studies show that unhealthy food patterns that are mainly high in dietary acid load (DAL) can lead to autoimmune blistering diseases by causing oxidative stress and inflammation24–2627–29. The concept of total DAL as comprehensive information about the nutritional intakes of subjects has received considerable attention in epidemiologic studies during the last decade30,31. DAL reflects the acid-forming potential of a diet32,33. An increase in acid load can lead to the response of autoreactive T cells. High dietary DAL can disrupt the immune system by increasing the production of arachidonic acid, and intestinal dysbiosis, creating regulatory T cells (Treg) and increasing inflammatory cytokines. An inverse association between the consumption of alkaloid food items, including fruits and vegetables, and protection against skin damage34. It also reported that the consumption of acidic foods, including red or processed meats is associated with the exacerbation of skin-related inflammatory disorders35. DAL seems to be a factor in the recurrence of the disease in autoimmune diseases. Since PV is an autoimmune disease, it can be related to DAL, but there is no similar study about the association of DAL with the severity of autoimmune bullous diseases including PV. The present study aimed to classify PV patients based on the severity of the disease and to evaluate its relationship with dietary acid load among Iranian PV patients to explore the details of the nutritional factors of this autoimmune blistering disease severity. The results will be more important for patients residing in the Middle East, who consume fewer fruits and vegetables and more refined grains such as white rice and bread. In addition, the results obtained could be useful for preventing the recurrence of symptoms or disease in susceptible individuals. Materials and methods Study design and participants A hospital cross-sectional study involving patients diagnosed with PV was performed in 2021. The adult PV patients who have been diagnosed for two months are referred to the pemphigus clinic of Razi Hospital, a specialized center for skin diseases in Iran. The diagnosis of PV was confirmed by a pathologist at the Pemphigus Clinic of Razi Hospital based on a positive direct immunofluorescence test as the gold standard for PV36. The number of samples was calculated using the following formula: (N= [(Zα + Z1 − β)/0.5×ln(1 + r/1 − r)]2 + 3. Using r = 0.30, 1 − β = 0.95 and α = 0.05 and considering types I and II error of 0.05). One hundred and thirty-eight adult patients with PV were included regardless of sex. The participants were patients aged 18–65 years with pathological confirmation of PV. The inclusion criteria for this study are men and women in the age range of 18–65 years, definitive diagnosis of PV disease, current or former smoking, stable disease, and ambulatory patients with a caloric intake range of 800–4200 kcal. Exclusion criteria were migration, pregnancy, breastfeeding, visit to a dietitian within the past year, malignancy problems, patients with low or high total energy intake (< 800 or 4200 > kcal/day), and history of inflammatory disease. An informed consent form was obtained from all participants. The current study was approved by the Ethics Committee of the Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1400.1450). All methods have been carried out in accordance with the relevant guidelines and regulations of the Ethics Committee of the Tehran University of Medical Sciences. The flowchart of the participant’s selection process is provided in Fig. 1. Participant’s flowchart. Assessment of dietary intake PV patients’ habitual dietary intake during the last year of study enrollment was collected using a valid semi-quantitative food frequency questionnaire37. In brief, the questionnaire consisted of 168 standard portion food items commonly consumed in Iran. The questionnaire was completed by a face-to-face interview with a trained nutritionist. Patients were asked to report how often, on average, a specific serving of each of the 168 foods was consumed per week or day during the past 12 months. Amounts in each serving size were converted to grams based on home measurements. Consumption in grams of each food item was converted to daily intake by dividing the weight of each food item consumed by the time factor (e.g. once a month divided by 30 and once a week divided by 7). In our study, only one general practitioner (GP) interviewed the patients. Also, the patients were enrolled in the study in the spring season, and the results of our study did not undergo seasonal variations. We did our best to reduce bias in this study. The participants’ average daily energy and macro- and micronutrient intakes were also calculated using the latest version of the Dietitian IV software (version 7.0; N-Squared Computing, Salem, Oregon, USA), which was designed for the evaluation of Iranian foods. Dietary acid load calculation Based on the capacity to release acids or bases in the blood circulation, PRAL can be calculated for all foods38. A positive PRAL in the diet indicates the production of more acidic precursors and a negative PRAL in the diet indicates the production of more alkaline precursors39. Initially, energy-adjusted intake of dietary protein (g/day), phosphorus (mg/day), potassium (mg/day), calcium (mg/day), and magnesium (mg/day) were estimated using the residual method40. Then, DAL based on the Net Endogenous Acid Production (NEAP) and Potential Renal Acid Load (PRAL) scores, were assessed by previously established algorithms21,41: PRAL (mEq/d) = 0.4888 × protein intake (g/day) + 0.0366 × phosphorus (mg/day) − 0.0205 × potassium (mg/day) − 0.0125 × calcium (mg/day) − 0.0263 × magnesium (mg/day). NEAP (mEq/d) = (54.5 × protein intake (g/day) ÷ potassium intake (mEq/day)) − 10.2. In general, fruits and vegetables have negative PRAL, and whole grains, meat, cheese, and eggs have positive PRAL18. Also, milk has neutral PRAL39. In addition, fats and sugars have little effect on acid-base balance22. Assessment of disease severity In this study, disease severity was assessed using the Pemphigus Disease Area Index (PDAI) scoring system, which was developed by the International Pemphigus Definition Committee. PDAI score’s validity and reliability have been determined in adults42,43. PDAI has a potential range from 0 to 26342. Out of 263 points, 250 points are assigned to disease activity, of which (120 points are for skin activity, 10 points for scalp activity, 120 points for mucosal activity) and 13 points for lesion-disease activity (for post-inflammatory hyperpigmentation)44. This score was assessed for the severity of pemphigus by observation and physical examination by a trained dermatologist assistant. After calculating each patient’s PDAI score based on the number and size of lesions in each anatomical region, patients were divided into two groups. According to previous studies we categorized participants into moderate (PDAI 15 or less) and severe (PDAI 15 or more)44,45. Assessment of other variables Data on participants’ general characteristics, medical history, and lifestyle variables including age (continues), sex (male/female), marital status (single/married), education (under university/university graduated), duration of disease (continues), being in a high-risk job (exposing to chemicals/none exposing to chemicals), corticosteroid use (less than 5 mg per day/ more than 5 mg per day of prednisolone), smoking (smoker/non-smoker), cumulative dose of rituximab (continues), having a history of any chronic disease including diabetes, hypertension, cardiovascular disease, hyperlipidemia, cancer, hypothyroidism, non-alcoholic fatty liver disease, polycystic ovary syndrome, viral infections and family history of the mentioned disease were collected using a general questionnaire. Anthropometric parameters were obtained by a trained GP based on the World Health Organization (WHO) recommendations. Weight (nearest 100 grams) was measured with light clothing without shoes using a digital scale (SECA, Hamburg, Germany), and height (nearest 0.1 cm) was measured using a non-elastic tape meter in standing status next to the wall while the patient’ shoulders were in a normal state and barefoot. Waist circumference was measured using a non-stretching tape measure between the last rib and the middle of the sternum. Body mass index (BMI) was calculated as the patients’ weights divided by height squared (kg m–2). Blood pressure measurement was done by one person using a standard-size sphygmomanometer cuff and a stethoscope, from both hands of the patient and following the necessary conditions after resting for at least 5 min and in a full sitting position46. Blood tests including lipid profile and blood sugar required fasting for 8–12 h47. Physical activity was assessed using the Internationally Approved Physical Activity Questionnaire (IPAQ), expressed as metabolic volume × time per day, and classified as mild, moderate, and intensive48. Statistical analysis The statistical analysis was done using SPSS software (SPSS Inc, Chicago IL - version 22.0). Statistical significance levels were set as P < 0.05. Categorical variables were presented as numbers and percentages. Continuous variables were presented as mean ± SD/SE. patients were categorized based on DAL and PDAI scores. Patients were categorized into tertile based on the distribution of DAL. We merged two categories of bottom tertiles into one category and was considered as reference. Comparison of general characteristics and dietary intakes between two categories of PDAI score was performed using an Independent Sample t-test and Chi-square or Fischer exact tests for continuous and ordinal qualitative variables, respectively. The association of dietary acid load (NEAP and PRAL, independent variables) with PDAI (dependent variable) was assessed using binary logistic regression in crude and separate models. A logistic regression analysis was used to predict the severity of PV disease following a one-unit increase in dietary acid load in crude and adjusted models. In all multivariate models, T1 and T2 were merged and considered as references. In the multivariable model, the potential confounding variables including (Model 1 adjusted for age, sex, and energy intake; Model 2 was adjusted for factors in Model 1 plus smoking, physical activity, education, and supplement use; Model 3 was adjusted for factors in Model 2 plus fiber and cholesterol intake; Model 4 was adjusted for factors in Model 3 plus corticosteroids use). Results The general characteristics of the subjects are demonstrated in Table 1. Women were 62% and 50% of subjects with low and high scores of PDAI respectively, however, the difference was insignificant (P = 0.2). Those with high scores of PDAI had shorter disease duration (P = 0.002) and received a higher dose of corticosteroids (P < 0.0001), and a lower dose of RTX (P = 0.01). In the matter of DAL, men were significantly placed in the top tertile of NEAP and PRAL (P = 0.002 and 0.001, respectively) and those in the third tertile of PRAL were mostly smokers (78.3%, P = 0.03). The mean of PRAL and NEAP was − 2.69 mEq/d and 57.72 mEq/d, respectively. Table 1Baseline characteristics of the study population by categories of PDAI score and DAL indexes.VariablesPDAI scoresPDAI ≤ 15PDAI > 15 P Number of patientsn = 108n = 30Demographic variables Age (year)c48.24 (12.44)48.33 (14.32)0.972 Sex, male/femaleb41/67 (38%, 62%)15/15 (50%, 50%)0.235 Weight (kg)c76.31 (14.50)76.8 (12.22)0.869 WC (cm)c86.94 (12.23)85.56 (12.46)0.588 BMI (kg/m2)c27.98 (4.73)27.15 (4.44)0.390 Smoking, yes/nob12/96 (11.1%, 88.9%)6/24 (20%, 80%)0.224PALb Milde45 (41.7%)13 (43.3%)0.855 Moderate48 (44.4%)14 (46.7%) Intensive15 (13.9%)3 (10%) University-education, yes/nob32/76 (29.6%, 70.4%)7/23 (23.3%, 76.7%)0.498 Marital status, single/marriedb15/93 (13.9%, 86.1%)6/24 (20%, 80%)0.400 High-risk job, yes/nob4/104 (3.7%, 96.3%)4/26 (13.3%, 86.7%)0.068 Residence, urban/ruralb101/7 (93.5%, 6.5%)29/1 (96.7%, 3.3%)1.000Medical history Disease duration (day)c5.37 (6.04)2.55 (3.71)0.002 Supplement use, yes/nob17/91 (15.7%, 84.3%)3/27 (10%, 90%)0.565 Corticosteroid medication (yes/no)#62/46 (57.4%, 42.6%)28/2 (93.3%, 6.7%)< 0.0001 RTX medication (cumulative dose)c2.73 (2.55)1.53 (1.70)0.016 MTX medication yes/nob6/102 (5.6%0.94.4%)0/30 (0%, 100%)0.339 Azathioprine, yes/nob1/107 (0.9%, 99.1%)2/28 (6.7%, 93.3%)0.119 Systolic BP (mmHg)c123.77 (10.23)125.66 (10.96)0.380 Diastolic BP (mmHg)c76.64 (6.56)77.16 (7.51)0.711Lab test FBS (mg/dl)c95.86 (19.26)103.36 (37.77)0.301 LDL (mg/dl)c103.56 (30.09)105.83 (32.43)0.720 HDL (mg/dl)c54.04 (11.62)52.46 (10.98)0.506 TG (mg/dl)c131.15 (61.02)157.03 (72.98)0.054 TC (mg/dl)c183.68 (35.96)187.76 (41.17)0.595 Anti-DSG1 positive/negative b24/84 (22.2%, 77.8%)11/19 (36.7%, 63.3)0.108 Anti-DSG3 positive/negative b51/41 (55.4%, 44.6%)12/3 (80%, 20%)0.073VariablesPRALNEAPLowest (< 9.30 mEq)Highest ( ≥ 9.30 mEq) P Lowest (< 51.50 mEq)Highest ( ≥ 51.50 mEq) P Number of patientsn = 92n = 46n = 92n = 46Demographic variables Age (year)c48.48 (1.29)47.80 (2.03)0.76848.00 (1.33)48.78 (1.92)0.737 Sex, male/femaleb28/64 (30.4%, 69.6%)28/18 (60.9%, 39.1%)0.00129/63 (31.5%, 68.5%)27/19 (58.7%, 41.3%)0.002 Weight (kg)c76.06 (14.05)77.14 (14.02)0.67276.19 (13.14)76.88 (15.72)0.800 WC (cm)c86.91 (12.13)86.10 (12.59)0.71786.82 (12.29)86.28 (12.29)0.807 BMI (kg/m2)c28.22 (4.67)26.96 (4.58)0.13628.03 (4.73)27.34 (4.54)0.413 Smoking, yes/nob8/84 (8.7%, 91.3%)10/36 (21.7%, 78.3%)0.03211/81 (12%, 88%)7/39 (15.2%, 84.8%)0.592PALb Milde35 (38%)23 (50%)0.01037 (40.2%)21 (45.7%)0.132 Moderate49 (53.3%)13 (28.3%)46 (50%)16 (34.8%) Intensive8 (8.7%)10 (21.7%)9 (9.8%)9 (19.6%) University-education, yes/nob21/71 (22.8%, 77.2)18/28 (39.1%, 60.9)0.04521/71 (22.8%, 77.2%)18/28 (39.1%, 60.9%)0.045 Marital status, single/marriedb11/81 (12%, 88%)10/36 (21.7%, 78.3%)0.13113/79 (85.9%, 14.1%)8/38 (17.4%, 82.6%)0.615 High-risk job, yes/nob4/88 (4.3%, 95.7%)4/42 (8.7%, 91.3%)0.4405/87 (5.4%, 94.6%)3/43 (6.5%, 93.5%)1.000 Residence, urban/ruralb87/5 (94.6%, 5.4%)43/3 (93.5%, 6.5%)1.00086/6 (93.5%, 6.5%)44/2 (95.7%, 4.3%)0.465Medical history Disease duration (day)c5.25 (6.33)3.76 (4.13)0.1005.12 (6.17)4.02 (4.68)0.289 Supplement use, yes/nob16/76 (17.4%, 82.6%)4/42 (8.7%, 91.3%)0.17117/75 (18.5%, 81.5%)3/43 (6.5%, 93.5%)0.060 Corticosteroid medication (yes/no)#57/35 (62%, 38%)33/13 (71.7%, 28.3%)0.25556/36 (60.9%, 39.1%)34/12 (73.9%, 26.1%)0.129 RTX medication (cumulative dose)c2.46 (2.36)2.50 (2.60)0.9312.46 (2.41)2.50 (2.51)0.931 MTX medication yes/nob4/88 (4.3%, 95.7%)2/44 (4.3%, 95.7%)1.0004/88 (4.3%, 95.7%)2/44 (4.3%, 95.7%)0.683 Azathioprine, yes/nob1/91 (1.1%, 98.9%)2/44 (4.3%, 95.7%)0.2581/91 (1.1%, 98.9%)2/44 (4.3%, 95.7%)0.358 Systolic BP (mmHg)c123.80 (10.16)124.95 (10.90)0.541123.20 (10.36)126.15 (10.27)0.117 Diastolic BP (mmHg)c76.58 (6.69)77.10 (6.94)0.67076.15 (6.74)77.97 (6.68)0.135Lab test FBS (mg/dl)c98.19 (25.65)96.15 (22.45)0.64798.36 (26.25)95.75 (20.84)0.560 LDL (mg/dl)c102.30 (29.47)107.56 (32.52)0.341101.72 (29.51)108.71 (32.22)0.206 HDL (mg/dl)c54.17 (11.31)52.76 (11.82)0.49754.51 (12.41)52.08 (9.20)0.243 TG (mg/dl)c130.13 (65.68)149.93 (60.01)0.091133.57 (65.79)142.88 (61.49)0.428 TC (mg/dl)c181.57 (38.61)190.56 (33.26)0.180182.02 (36.66)189.67 (37.67)0.254 Anti-DSG1, positive/negative b20/72 (21.7%, 78.3%)15/31 (32.6%, 67.4%)0.16720/72 (21.7%, 78.3%)15/31 (32.6%, 67.4%)0.167 Anti-DSG3, positive/negative b42/33 (56%, 44%)21/11 (65.6%, 34.4%)0.35440/32 (55.6%, 44.4%)23/12 (65.7%, 34.3%)0.316WC waist circumference, BMI body mass index, PAL physical activity level, MH past medical history, PDAI pemphigus disease area index, RTX rituximab, MTX methotrexate, FBS fasting blood sugar, LDL low density lipoprotein, HDL high density lipoprotein, TG triacylglycerol, TC total cholesterol, RTX Medication rituximab cumulative dose, Anti-DSG1 anti-desmoglein1 antibodies, Anti-DSG3 anti-desmoglein3 antibodies.PMH: diabetes, hypertension, cardiovascular disease, hyper-lipidemia, cancer, hypothyroidism, non-fatty liver disease.Supplement of vitamins and minerals.aChi-square test for ordinal qualitative variables and independent samples T test for continuous variables. bN (%). cMean ± SD.#Corticosteroid Medication: less than 5 mg per day/more than 5 mg per day of prednisolone. Baseline characteristics of the study population by categories of PDAI score and DAL indexes. WC waist circumference, BMI body mass index, PAL physical activity level, MH past medical history, PDAI pemphigus disease area index, RTX rituximab, MTX methotrexate, FBS fasting blood sugar, LDL low density lipoprotein, HDL high density lipoprotein, TG triacylglycerol, TC total cholesterol, RTX Medication rituximab cumulative dose, Anti-DSG1 anti-desmoglein1 antibodies, Anti-DSG3 anti-desmoglein3 antibodies. PMH: diabetes, hypertension, cardiovascular disease, hyper-lipidemia, cancer, hypothyroidism, non-fatty liver disease. Supplement of vitamins and minerals. aChi-square test for ordinal qualitative variables and independent samples T test for continuous variables. bN (%). cMean ± SD. #Corticosteroid Medication: less than 5 mg per day/more than 5 mg per day of prednisolone. As reported by Table 2, on the one hand, those with higher scores of PDAI, consume a higher amount of red meat and processed one, white meat, and dietary cholesterol. On the other hand, a lower amount of dietary fiber, total and high-risk fruits, total and high-risk vegetables, total and high-risk nuts, and vitamin C, was consumed by the aforementioned group (P < 0.05 for all). Concerning DAL indexes, the top tertile of the indexes was significantly associated with high intakes of protein, dietary cholesterol, phosphorus, zinc, riboflavin, niacin, red meat and processed one, and white meat while it was associated with low consumption of dietary fibers, total and high-risk fruits, total and high-risk vegetables, total and high-risk nuts, α-linolenic acid, magnesium, selenium, potassium, vitamin A, beta-carotene, α-tocopherol, folic acid, vitamin B6, and vitamin C (P < 0.05 for all). Table 2Daily dietary intake of the study population between categories of PDAI score and DAL indexes.VariablesPDAI scorePRALNEAP(score ≤ 15)(score > 15) P LowestHighest P LowestHighest P Kcal (kcal/day)2283.762275.710.9522212.272421.490.0732262.362321.310.615Macronutrients Protein (g/day)90.01 (28.52)91.90 (25.89)0.74382.66 (22.01)105.93 (31.92)< 0.000185.28 (22.82)100.69 (33.95)0.007 CHO (g/day)327.09 (97.31)323.65 (115.21)0.870323.36 (98.40)332.31 (106.97)0.626326.35 (102.59)326.34 (98.97)1.000 Fat (g/day)74.65 (28.10)73.31 (27.37)0.81771.99 (27.03)79.12 (29.14)0.15775.59 (28.70)71.91 (26.19)0.466Fat-subgroup Cholesterol (mg/day)267.00 (124.01)334.59 (186.15)0.020241.70 (101.52)361.69 (175.02)< 0.0001249.16 (100.50)346.76 (185.38)0.001 SFA (g/day)22.21 (9.58)22.59 (9.97)0.85221.62 (9.75)23.65 (9.32)0.24422.61 (9.77)21.66 (9.40)0.586 MUFA (g/day)21.78 (9.41)21.65 (8.480)0.94220.80 (9.07)23.66 (9.21)0.08421.71 (9.34)21.85 (8,97)0.933 PUFA (g/day)15.48 (7.64)14.16 (5.98)0.38414.73 (6.56)16.12 (8.63)0.34015.89 (7.92)13.81 (5.75)0.081 Oleic (g/day)19.19 (9.82)17.59 (7.72)0.41118.57 (10.10)19.38 (7.88)0.63419.07 (9.97)18.39 (8.22)0.693 Linoleic (g/day)12.84 (7.34)11.96 (5.80)0.54712.12 (6.43)13.71 (8.06)0.21113.14 (7.73)11.65 (5.30)0.187 Linolenic (g/day)0.10 (0.11)0.14 (0.12)0.1470.11 (0.11)0.12 (0.12)0.7220.12 (0.13)0.08 (0.07)0.018 EPA (g/day)0.03 (0.04)0.03 (0.04)0.9740.02 (0.04)0.03 (0.04)0.5520.02 (0.04)0.03 (0.04)0.564 DHA (g/day)0.07 (0.10)0.07 (0.09)0.9740.06 (0.10)0.07 (0.10)0.5520.06 (0.09)0.07 (0.10)0.564Minerals Iron (mg/day)20.50 (9.38)21.25 (14.18)0.07319.76 (9.00)22.48 (13.04)0.15420.88 (10.94)20.24 (9.85)0.738 Zinc (mg/day)9.52 (3.21)9.49 (3.29)0.9578.92 (2.70)10.70 (3.82)0.0069.43 (2.88)9.69 (3.83)0.663 Coper (mg/day)1.39 (0.64)1.24 (0.55)0.2291.32 (0.59)1.43 (0.68)0.3411.41 (0.62)1.26 (0.63)0.182 Selenium (mg/day)0.03 (0.03)0.05 (0.04)0.1080.04 (0.03)0.04 (0.03)0.5740.04 (0.03)0.03 (0.03)0.032 Sodium4814.474330.990.3114763.28)4601.55)0.6994589.204949.70)0.388Vitamin-fat soluble VitA (µg/d)1604.761420.570.3801657.251379.660.1301729.871234.420.006 Beta-carotene993.48 (908.74)827.03 (794.36)0.3641030.11 (914.23)811.65 (814.87)0.1731081.46 (940.07)708.97 (710.69)0.019 VitE (mg/day)4.27 (1.78)4.22 (1.38)0.8894.26 (1.75)4.25 (1.60)0.9844.36 (1.73)4.05 (1.63)0.318 Alpha-tocopherol10.37 (8.08)8.84 (7.30)0.3519.52 (6.72)11.07 (9.90)0.34311.12 (8.70)7.87 (5.54)0.009 VitD (mg/day)1.94 (1.44)2.38 (1.74)0.1561.98 (1.47)2.16 (1.61)0.5102.21 (1.62)1.69 (1.23)0.060 VitK204.93 (107.36)205.89 (111.20)0.966207.60 (113.10)200.23 (97.31)0.706214.20 (112.97)187.02 (95.19)0.163Vitamin-water soluble VitB1 (mg/day)1.76 (0.54)1.76 (0.59)0.9651.68 (0.48)1.91 (0.64)0.0361.70 (0.52)1.88 (0.59)0.070 VitB2 (mg/day)1.73 (0.57)1.87 (0.59)0.2421.67 (0.54)1.94 (0.60)0.0101.76 (0.55)1.77 (0.63)0.883 VitB3 (mg/day)21.31 (7.08)21.42 (6.25)0.93619.63 (5.60)24.75 (7.94)< 0.000119.92 (5.93)24.16 (7.82)0.002 VitB5 (mg/day)6.06 (2.00)5.88 (1.90)0.6655.79 (1.86)6.47 (2.13)0.0576.15 (1.99)5.76 (1.93)0.275 VitB6 (mg/day)1.58 (0.65)1.37 (0.55)0.1141.53 (0.62)1.55 (0.68)0.8751.62 (0.65)1.36 (0.57)0.027 VitB7 (mg/day)26.50 (9.35)27.99 (9.96)0.44825.76 (8.84)28.96 (10.39)0.06226.62 (8.74)27.24 (10.88)0.719 VitB9 (µg/day)345.17 (113.68)314.96 (103.03)0.191340.49 (102.76)334.82 (129.10)0.780352.78 (103.49)310.25 (123.08)0.035 VitB12 (µg/day)4.83 (3.80)5.57 (3.48)0.3384.57 (3.10)5.82 (4.66)0.0634.76 (3.10)5.45 (4.74)0.302 VitC (mg/day)178.88 (102.39)114.80 (61.33)0.001181.44 (108.42)131.98 (63.70)0.005183.17 (108.34)128.51 (61.02)< 0.0001Fiber-subgroup Fiber (g/day)19.14 (6.88)15.61 (5.79)0.01119.01 (6.97)17.08 (6.32)0.11719.55 (6.90)16.00 (5.97)0.003 Soluble fiber (g/day)0.88 (0.44)0.68 (0.40)0.0320.90 (0.47)0.71 (0.36)0.0180.92 (0.47)0.66 (0.31)0.001 Insoluble fiber (g/day)4.70 (2.24)3.48 (1.90)0.0074.82 (2.36)3.66 (1.67)0.0044.89 (2.34)3.52 (1.63)< 0.0001Food groups Total-fruit215.69116.110.010221.09139.960.003221.58138.970.014 High risk-fruit^5.53 (0.57)5.06 (0.76)< 0.00015.51 (0.62)5.25 (0.65)0.0195.53 (0.59)5.21 (0.68)0.006 Total-vegetables193.21140.400.018195.08155.030.041201.42142.340.002 High risk-vegetables^4.53 (0.95)4.146 (1.03)0.0534.58 (0.86)4.17 (1.15)0.0204.56 (0.92)4.23 (1.06)0.064 Red-meat and pressed food67.2675.910.42360.5286.390.00662.5082.420.034 White meat99.58104.580.67382.38137.24< 0.000183.15135.70< 0.0001 Total-nut2.38 (1.05)1.79 (1.10)0.0082.33 (1.00)2.10 (1.22)0.2312.46 (1.08)1.83 (0.96)0.001 High risk-nut^4.64 (5.42)2.19 (3.48)0.0044.63 (5.71)3.04 (3.60)0.0484.81 (5.71)2.69 (3.42)0.008Independent sample T test; mean ± SD.^Fruits, nuts, and vegetables that contain phenols, thiols, tannins, and thiocyanates are classified as high-risk foods. Daily dietary intake of the study population between categories of PDAI score and DAL indexes. Independent sample T test; mean ± SD. ^Fruits, nuts, and vegetables that contain phenols, thiols, tannins, and thiocyanates are classified as high-risk foods. Considering the findings of multiple logistic regression (Table 3), a positive association was observed between PRAL and PDAI score in the crude (P < 0.0001) and all other adjusted models, as well as the crude model for NEAP ( P = 0.013). In terms of the adherence to NEAP and PRAL (Table 3), those in the top tertile of PRAL had a higher vulnerability for severe PV in unadjusted (OR = 5.18, 95% (CI) 2.19–12.25) and adjusted models versus other tertiles (model 4: OR = 5.75, 95% (CI) 1.68–9.65) plus subjects in the third tertile of NEAP in the unadjusted model were 2.48 times (OR = 2.48, 95% (CI) 1.08–5.68) more likely to have severe PV as opposed to the first and second tertiles. Table 3Odds ratio (OR) and 95% confidence interval and logistic regression for the association between dietary acid load and pemphigus disease area index score.Adherence to dietary acid loadP trendLowestHighestPRAL Crude1.00 (ref)5.18(2.19–12.25)< 0.0001 Model 11.00 (ref)5.41(2.16–13.57)< 0.0001 Model 21.00 (ref)7.66(2.72–21.60)< 0.0001 Model 31.00 (ref)4.89(1.54–15.50)0.007 Model 41.00 (ref)5.75(1.68,19.65)0.005NEAP Crude1.00 (ref)2.48(1.08–5.68)0.031 Model 11.00 (ref)2.31(0.98–5.45)0.057 Model 21.00 (ref)2.71(1.08–6.80)0.333 Model 31.00 (ref)1.22(0.41–3.60)0.726 Model 41.00 (ref)1.15(0.37,3.60)0.811Model 1 was adjusted for age (as continuous), sex (categorical), and energy intake (as continuous).Model 2 adjusted factors in model 1 plus smoking (as categorical), physical activity (as categorical), education (as categorical), and supplement use (categorical).Model 3 was adjusted for factors in model 2 plus fiber and cholesterol intake (as continuous) ,.Model 4 was adjusted for factors in model 3 plus and corticosteroid use (as categorical).*Logestic regression. Odds ratio (OR) and 95% confidence interval and logistic regression for the association between dietary acid load and pemphigus disease area index score. Model 1 was adjusted for age (as continuous), sex (categorical), and energy intake (as continuous). Model 2 adjusted factors in model 1 plus smoking (as categorical), physical activity (as categorical), education (as categorical), and supplement use (categorical). Model 3 was adjusted for factors in model 2 plus fiber and cholesterol intake (as continuous) ,. Model 4 was adjusted for factors in model 3 plus and corticosteroid use (as categorical). *Logestic regression. Discussion In this cross-sectional study, we hypothesized the association between dietary acid load and severity of pemphigus vulgaris among Iranian adults. We found a significant positive association between dietary acid load, estimated by PRAL and NEAP scores, and PV severity. This association remained significant even after adjusting for a wide range of covariates in the PRAL index. Moreover, each unit increase in DAL score was associated with a significant increase in the severity of the disease which is estimated by the PDAI score. PRAL and NEAP are two scores that have been used to estimate the acidic load of the diet49,50. Higher values of these indexes indicate higher diet acidity51–53. In the present study, mean of PRAL (mean, PRAL: − 2.69 mEq/d) and NEAP (mean, NEAP: 57.72 mEq/d) values showed higher acidity compared with other studies in healthy (mean, PRAL − 11.2 mEq/d; mean, NEAP 35.6 mEq/d) and diabetic Iranian adults (median, PRAL − 0.32 mEq/d; median, NEAP − 0.28 mEq/d)54–56. The difference in the mean of PRAL and NEAP may be due to the difference in the amount of oral lesions of the participants of the studies. Because the increase in oral lesions causes a decrease in grain consumption. Considering that the acidic load of the diet in Iranians is high due to the high consumption of refined grains such as white rice, salt, and sweet non-alcoholic beverages, this finding was inconsistent with studies conducted on Asian populations52. Maintaining the body’s acid-base balance is essential for the organs’ function and life. Based on previously published studies, acidogenic diets are typically rich in animal proteins, dairy products, processed foods, eggs, and high-energy drinks and low in fruits and vegetables57,58. In another study, it was shown that the type of dietary fats can affect the severity of PV; so the increase in cholesterol saturated index (CSI) score with increased DAL was associated with the increase in severity of PV59. However, the relation between PUFA: SFA ratio and ω-6/ω-3 index with PV severity is not significant (unpublished data). Also, adherence to the Alternative Healthy Eating Index 2010 (AHEI-2010) is strongly related to the reduction of PV severity14. Anti-inflammatory diets that are associated with increased consumption of vegetables, fruits, whole grains, and legumes can reduce the complications caused by PV by reducing inflammation60. Deficiency of micronutrients such as copper, zinc, and selenium deficiency can be effective in the occurrence and recurrence of PV65–67. Also, the lack of vitamin C can lead to the occurrence of cutaneous diseases, such as PV68.In addition, the consumption of foods with high acidity, such as red meat, can lead to an increase in inflammatory diseases of the digestive system by increasing the DAL of the diet69. In a study that investigated the effect of dietary acid load on autoimmune celiac disease, it was shown that the mean value of PRAL was negative in the celiac group, but positive in the placebo group70. Also, the average score of NEAP and DAL was much lower in patients with celiac disease compared to healthy people70. The studies conducted in this field are very limited and the exact mechanism by which an acid-base imbalanced diet influences the severity of PV disease is largely unknown. Increased acid was associated with an increased risk of cardiovascular disease (CVD), nonalcoholic fatty liver disease (NAFLD), and metabolic syndrome (MetS) via increasing hemoglobin A1c (HbA1c) levels and insulin resistance31,71–74. One possible explanation for the direct association between DAL and PDAI score might be the effects of metabolic acidosis induced by higher DAL on enhanced proteolysis via increased messenger RNA (mRNA) encoding of the proteasome pathway proteins75. Also, metabolic acidosis increases insulin resistance through increased gluconeogenesis and impaired insulin receptor signaling76. On the other hand, wound healing progress is highly dependent on metabolic acidosis, and nutritional and hormonal status13,77,78. Acidosis diet with active signaling of receptor activator of nuclear factor kappa beta (NF-kB) ligand (RANKL) can lead to stimulation of osteoclastic resorption79,80. On the other hand, oxidative stress and inflammation appear to be responsible for the initiation/aggravation of autoimmune bullous disease including PV81,82. MAPK p38 activity during acantholysis can be associated with induction of apoptosis83. Moreover, researchers observed that the antioxidant capacity has decreased in PV patients which leads to NF-kB and MAPK-signaling activation84–88. Similarly, we observed that in patients with high severity of the disease, consumptions of fiber and vitamin C were lower. In addition, metabolic acidosis induced by high DAL can lead to a disturbance in the process of wound healing through its impact on the NF-kB pathway89. Therefore, it seems that low DAL in this study affected the severity of the disease through the inhibition of the inflammatory pathways. In our study, we observed that patients with a lower DAL index had higher intakes of fiber (total, soluble, and in soluble), magnesium, potassium, folic acid, vitamin B6, vitamin A, and beta-carotene. Adherence to diets rich in alkaloid foods such as fruit and vegetables which are a main source of fiber, potassium, antioxidants different vitamins, and minerals, each compound can independently have a beneficial effect through decreasing inflammatory markers and subsequently preventing the progression of the PV disease17. In addition, acid-base disequilibrium per se may be effected adipocyte cytokine signaling in particular interleukin-1beta (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α)90,91. Finally, the association between low DAL with less severity of the disease may be related to its high dietary fiber content. short-chain fatty acids produced from dietary fibers by anaerobic bacteria in the large bowel controlled skin immune responses via increasing Tregs‏ and the function of innate immune cells92. This study is the first report on the association of dietary acid load DAL, estimated by PRAL and NEAP scores and severity of PV disease while considering the effect of several confounding factors. Also, this study was conducted in a highly prevalent region for PV where the associations between diet and a rare disease like PV can provide valuable information about dietary risk factors of disease. However, this study had some limitations which should be considered in the interpretation of findings. First, due to the cross-sectional design of the study causality cannot be inferred. Second, misclassification of study participants as a result of the use of a food frequency questionnaire (FFQ) in order to evaluate the dietary intake. Third, it is possible that the nature of the disease and the presence of ulcers and involvement of the oral mucosa have influenced the type of food consumed, and the eating behaviors of these patients and might change dietary intakes. Fourth, considering that our sample size is relatively large in this rare disease, we can generalize to all PV patients. However, due to the cross-sectional nature of the study, it is better to use the results in PV patients with caution. Fifth, other components of a diet might also influence body acid-base regulation. Also, it is unclear whether the underlying association between DAL and the severity of PV disease was caused by the acidity of the diet or if it was due to minerals present in the DAL formula. Conclusion In conclusion, this cross-sectional study revealed chronic consumption of a high dietary acid load predicts the severity of disease among patients with pemphigus vulgaris. In other words, dietary modifications can be considered as potential adjunctive therapies for PV patients. Further prospective studies with larger sample sizes are needed to confirm these initial findings. Acknowledgements All Study was supported by the Tehran University of Medical sciences, Tehran, Iran. The authors would also like to thank all patients who took part in this study. Author contributions KB, MD and SE-K contributed to the design. AN contributed to the data collection. MF, BJA and ZE contributed to the manuscript drafting, statistical analyses and conducted research. MF, BJA and SE-K contributed to the data interpretation, and approval the final version of manuscript. SE-K supervised the study and has primary responsibility for the final content. SE-K has responsibility for all parts of the manuscript. All authors read and approved the final manuscript. The authors declare that they have no conflict of interest. SE-K had full access to all the data in the study and had primary responsibility for final content. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Data availability The datasets generated and/or analyzed during the current study are not publicly available because this study was carried out using the facilities of Tehran University of Medical Sciences and all publication rights belong to it but are available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally:Maryam Fallah and Banafsheh Jafari Azad. References Associated Data Data Availability Statement The datasets generated and/or analyzed during the current study are not publicly available because this study was carried out using the facilities of Tehran University of Medical Sciences and all publication rights belong to it but are available from the corresponding author on reasonable request.